NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Intersect ENT Inc (F: 7IN)

 
7IN Technical Analysis
5
As on 12th May 2022 7IN STOCK Price closed @ 27.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 18.89 & Strong Buy for SHORT-TERM with Stoploss of 18.94 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

7INSTOCK Price

Open 26.40 Change Price %
High 27.00 1 Day 0.40 1.50
Low 26.40 1 Week 1.00 3.85
Close 27.00 1 Month 2.00 8.00
Volume 87 1 Year 11.20 70.89
52 Week High 26.60 | 52 Week Low 13.50
 
F Germany Most Active Stocks
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
 
F Germany Top Gainers Stocks
JYR 1000000.00 10000000000.00%
JYR 1000000.00 10000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
1S9 0.20 1900.00%
 
F Germany Top Losers Stocks
31R 0.00 -100.00%
5C5 0.00 -100.00%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
 
 
7IN
Daily Charts
7IN
Intraday Charts
Whats New @
Bazaartrend
7IN
Free Analysis
 
7IN Important Levels Intraday
RESISTANCE28.16
RESISTANCE27.79
RESISTANCE27.56
RESISTANCE27.33
SUPPORT26.67
SUPPORT26.44
SUPPORT26.21
SUPPORT25.84
 
7IN Forecast April 2025
4th UP Forecast33.17
3rd UP Forecast31.19
2nd UP Forecast29.97
1st UP Forecast28.74
1st DOWN Forecast25.26
2nd DOWN Forecast24.03
3rd DOWN Forecast22.81
4th DOWN Forecast20.83
 
7IN Weekly Forecast
4th UP Forecast30.66
3rd UP Forecast29.49
2nd UP Forecast28.76
1st UP Forecast28.04
1st DOWN Forecast25.96
2nd DOWN Forecast25.24
3rd DOWN Forecast24.51
4th DOWN Forecast23.34
 
7IN Forecast2025
4th UP Forecast53.4
3rd UP Forecast44.93
2nd UP Forecast39.7
1st UP Forecast34.47
1st DOWN Forecast19.53
2nd DOWN Forecast14.3
3rd DOWN Forecast9.07
4th DOWN Forecast0.6
 
 
7IN Other Details
Segment EQ
Market Capital 766944064.00
Sector Healthcare
Industry Medical Devices
Offical website >
 
7IN Address
7IN
 
7IN Latest News
 
Your Comments and Response on Intersect ENT Inc
 
7IN Business Profile
Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL and PROPEL Mini, which are steroid releasing implants for patients undergoing sinus surgery to treat chronic sinusitis; and PROPEL Contour, a steroid releasing implant to frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for the treatment of patients in the physician office setting; VENSURE Navigable and Stand-alone balloon, a sterile and single-use device, used to access and treat frontal, sphenoid sinus, and maxillary ostia in adults using a trans-nasal approach; and CUBE Navigation System, a virtual guidance platform for high precision ENT and ENT related skull-base surgeries. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California. Address: 1555 Adams Drive, Menlo Park, CA, United States, 94025
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service